Hvivo (HVO) RNS Announcements

Add to Alert list
Date Time Source Announcement
06 Jan 2020 07:00 AM
RNS
New 3 Year Contract
02 Jan 2020 11:44 AM
RNS
Form 8.3 - Open Orphan PLC
31 Dec 2019 07:00 AM
RNS
Offer Update
27 Dec 2019 08:01 AM
RNS
Rule 2.9 Announcement
20 Dec 2019 05:39 PM
RNS
Form 8.3 - Open Orphan Plc
19 Dec 2019 01:36 PM
RNS
Form 8.3 - Open Orphan plc
19 Dec 2019 01:09 PM
RNS
Exercise of Share Options
19 Dec 2019 12:48 PM
EQS
HVIVO PLC
19 Dec 2019 08:01 AM
RNS
Rule 2.9 Announcement
18 Dec 2019 07:00 AM
RNS
New Contract with SFA Therapeutics
17 Dec 2019 04:36 PM
RNS
Form 8 (OPD)
17 Dec 2019 10:19 AM
RNS
Form 8 (OPD)
17 Dec 2019 10:19 AM
RNS
Form 8 (OPD) (hVIVO plc)
13 Dec 2019 01:52 PM
RNS
Exercise of Share Options
11 Dec 2019 07:00 AM
RNS
Form 8 (OPD)
11 Dec 2019 07:00 AM
RNS
Form 8 (OPD)
10 Dec 2019 07:00 AM
RNS
Rule 2.9 Announcement
10 Dec 2019 07:00 AM
RNS
Rule 2.9 Announcement
09 Dec 2019 01:27 PM
RNS
Total Voting Rights
09 Dec 2019 01:10 PM
RNS
Total Voting Rights
09 Dec 2019 07:00 AM
RNS
Recommended Merger of hVIVO with Open Orphan
09 Dec 2019 07:00 AM
RNS
Recommended All-Equity Offer
25 Nov 2019 07:00 AM
RNS
Early adopters signed for Genomic Health DataBANK
18 Nov 2019 07:00 AM
RNS
Contract signed with Carna Bioscience
15 Nov 2019 07:00 AM
RNS
Jefferies 2019 London Healthcare Conference
11 Nov 2019 02:19 PM
RNS
Exercise of Share Options
11 Nov 2019 07:00 AM
RNS
Preferred Partner Agreement
24 Oct 2019 07:00 AM
RNS
Value the Markets Webinar
21 Oct 2019 07:00 AM
RNS
Investor Event Attendance and Presentation
17 Oct 2019 03:20 PM
RNS
Holding(s) in Company
16 Oct 2019 09:49 AM
RNS
Holding(s) in Company
15 Oct 2019 07:00 AM
RNS
Agreement signed with Empiric Logic
08 Oct 2019 07:00 AM
RNS
Investor Event Attendance and Presentation
03 Oct 2019 09:51 AM
RNS
Director's Dealings
02 Oct 2019 05:03 PM
RNS
Exercise of Share Options
02 Oct 2019 03:58 PM
RNS
Result of AGM
01 Oct 2019 11:08 AM
RNS
Holding(s) in Company
27 Sep 2019 07:00 AM
RNS
hVIVO to present at ERS International Congress
25 Sep 2019 07:00 AM
RNS
Interim Results for 6 months ended 30 June 2019
23 Sep 2019 03:39 PM
RNS
Exercise of Warrants and Issue of Shares
19 Sep 2019 07:00 AM
RNS
Interim Results 2019
16 Sep 2019 07:00 AM
RNS
Investor Event Attendance and Presentation
12 Sep 2019 07:00 AM
RNS
Notice of AGM
10 Sep 2019 07:00 AM
RNS
Investor Event Attendance and Presentation
09 Sep 2019 07:00 AM
RNS
Investor Event Attendance and Presentation
03 Sep 2019 07:00 AM
RNS
Investor Event Attendance and Presentation
02 Sep 2019 07:00 AM
RNS
Upcoming Investor Events
23 Aug 2019 07:00 AM
RNS
Notice of Interim Results
06 Aug 2019 07:00 AM
RNS
Successful RSV Challenge Study in Older Adults
01 Aug 2019 07:00 AM
RNS
Directorate Changes

hVIVO is a contract research organization that conducts human challenge clinical trials for respiratory and infectious disease vaccines and therapeutics:

hVIVO offers services such as challenge trials, assay development, field trial bio-logistics, cell based assays, molecular services, compound efficacy and VRM, and biomarker analysis.

Formerly known as Retroscreen, hVIVO was renamed in 2015 when it went public on the London Stock Exchange.

hVIVO has a portfolio of 11 human challenge models, with more models in development. Their portfolio includes models for influenza, respiratory syncytial virus, human rhinovirus, asthma, COPD, cough, malaria, COVID-19, and hMPV.

hVIVO share price launched at 33p in 2012.

UK 100

Latest directors dealings